Mary Ann Grant – Foundation built from Dressage Family - Preparing for the 2014 Winter Dressage Season
Wednesday, November 20, 2013
Posted by Betsy LaBelle
She shared, "My primary goal right now is to be ready for the 2015 Pan American Games in Toronto. I have two fantastic horses, and feel so lucky and appreciative to have them in my life. Beilando is a seven year old dark chestnut gelding (Belissimo M X Don Primero). He has a lot of character and a fantastic gallop. I call him Secretariat. Weltregentrin is a 9 year old chestnut mare (Weltregent H X Lauries Crusader). She is very intelligent and special. She knows my footsteps and always greats me with a whinny. I have been with her since she was two years old. My mother bred her.
Loreto HM is a two year old chestnut colt (Londonderry X Don Bosco) who is beginning his training. He has three super gaits and a good character, and will be a great horse for the future. I really enjoy the process of bringing young horses along to Grand Prix. I am so happy when I feel the horses are really trying for me. That is the greatest part about riding, the partnership you make with a horse.
Our farm is located in Wellington, Florida. We have 25 acres, 16 stalls, many paddocks, a large grass field for riding, a large outdoor ring, lunging pen, and miles of trails to ride. Our new addition is a covered arena. We are planning to build a galloping track, and also put a few cross country jumps in the grass field.
Leukemia and Lymphoma Society:
"As a survivor of Lymphoma, I make it my mission to raise money for the Leukemia and Lymphoma Society. Determined to help in some way even before I finished my own treatment, I was inspired by the courage I saw in other patients, especially the children and their families. I met with the LLS Palm Beach Chapter with an idea for a fundraiser in Wellington, and they encouraged me. The first annual event started in 2003. I thought we could raise $5000.00 that year, and we ended up raising $120,000.00. The equestrian community was amazing and that gave me the confidence to carry on as chair through 2012.
I serve on the LLS South Florida Board, which allows me to stay current with how funds raised are used for research and patient services. The FDA just approved a new therapy called Gazyva, for Chronic Lymphocytic Leukemia (CLL). It is an antibody which binds to the CD20 protein expressed on the surface of B cells, which are present in many types of cancer. Once bound to these cells, Gazyva causes cancer cells to die by engaging the patient’s own immune system. We believe that in our lifetime breakthroughs like Gazyva will cure cancer.
Posted on Jan 18, 2013
Posted on Apr 17, 2009
Posted on Mar 26, 2003
Posted on Nov 25, 2013